2Bonner JA, Sloan JA, Rowland KM Jr, et al. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Clin Cancer Res,2000,6(2) : 597-601.
3Fizazi K, Cojean I, Pignon JP, et al. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma. Cancer, 1998,82(6) : 1049-1055.
4Pujol JL, Boher JM, Grenier J, et al. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Lung Cancer,2001,31(2-3) : 221-231.
5Plebani M, Basso D, Navaglia F, et al. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Br J Cancer, 1995,72(1) : 170-173.
6Ferrer J, Villarino MA, Encabo G, et al. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer,1999,86(8):1488-1495.
7Shibayama T, Ueoka H, Nishii K, et al. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer(SCLC). Lung Cancer,2001,32(1) : 61-69.
8Stieber P, Dienemann H, Schalhorn A, et al. Pro-gastrin-releasing peptide (ProGRP)-a useful marker in small cell lung carcinomas. Anticancer Res, 1999,19(4A) : 2673-2678.
9Goto K, Kodama T, Hojo F, et al. Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin-releasing peptide levels. Cancer, 1998, 82 (6):1056-1061.
10Shijubo N, Hirasawa M, Sasaki H, et al. Elevated progastrin-releasing peptide(31-98) concentrations in pleural effusions due to small-cell lung carcinoma. Respiration, 1996,63(2) : 106-110.
2Castaldi F.Marion M.Beneduce L,et al.Detection of eirculating CEA- lgM complexes in early stage colorectal cancer [J].Int J Biol Markers, 2005,20 (4) : 204-208.
3Sorbye H,Dahl O.Carcinoembryonic antigen surge in metastatic col- orectal cancer patients responding td oxaliplatin combination chemotherapy:implications for tumor marker monitoring and guidelines [J ].J C lin O ncol.2003,21 (23) :4 466-4 467.
4Folkman J.Angiogenesis in cancer,cascular,rhenmatoid and other dis- casc [J] ,Nature Med, 1995,1:27.
